0001209191-24-002992.txt : 20240208
0001209191-24-002992.hdr.sgml : 20240208
20240208161110
ACCESSION NUMBER: 0001209191-24-002992
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240206
FILED AS OF DATE: 20240208
DATE AS OF CHANGE: 20240208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zakrzewski Joseph S
CENTRAL INDEX KEY: 0001331852
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40499
FILM NUMBER: 24609195
MAIL ADDRESS:
STREET 1: 509 WATERVIEW PLACE
CITY: NEW HOPE
STATE: PA
ZIP: 18938
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662244
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 455429901
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: BUILDING B, SUITE 450
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 857-285-4140
MAIL ADDRESS:
STREET 1: 99 HAYDEN AVENUE
STREET 2: BUILDING B, SUITE 450
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-06
0
0001662244
Cyteir Therapeutics, Inc.
CYT
0001331852
Zakrzewski Joseph S
C/O CYTEIR THERAPEUTICS, INC.
99 HAYDEN AVE, BUILDING B, SUITE 450
LEXINGTON
MA
02421
1
0
0
0
0
Common Stock
2024-02-06
4
M
0
14150
1.69
A
227439
D
Common Stock
149051
I
See Footnote
Stock Option (Right to Buy)
1.69
2024-02-06
4
M
0
14150
0.00
D
2024-02-03
2033-02-03
Common Stock
14150
0
D
Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
/s/ David Gaiero, as attorney-in-fact for Joseph S. Zakrzewski
2023-02-08